X-1303972-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBP6_ModerateBP7BS2_Supporting
The NM_172245.4(CSF2RA):c.996C>T(p.Ile332Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,613,312 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., 2 hem., cov: 31)
Exomes 𝑓: 0.000010 ( 0 hom. 6 hem. )
Consequence
CSF2RA
NM_172245.4 synonymous
NM_172245.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.182
Genes affected
CSF2RA (HGNC:2435): (colony stimulating factor 2 receptor subunit alpha) The protein encoded by this gene is the alpha subunit of the heterodimeric receptor for colony stimulating factor 2, a cytokine which controls the production, differentiation, and function of granulocytes and macrophages. The encoded protein is a member of the cytokine family of receptors. This gene is found in the pseudoautosomal region (PAR) of the X and Y chromosomes. Multiple transcript variants encoding different isoforms have been found for this gene, with some of the isoforms being membrane-bound and others being soluble. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant X-1303972-C-T is Benign according to our data. Variant chrX-1303972-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 537345.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.182 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 2 XL geneVariant has number of hemizygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSF2RA | NM_172245.4 | c.996C>T | p.Ile332Ile | synonymous_variant | 11/13 | ENST00000381529.9 | NP_758448.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSF2RA | ENST00000381529.9 | c.996C>T | p.Ile332Ile | synonymous_variant | 11/13 | 1 | NM_172245.4 | ENSP00000370940.3 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151536Hom.: 0 Cov.: 31 AF XY: 0.0000270 AC XY: 2AN XY: 73956
GnomAD3 genomes
AF:
AC:
2
AN:
151536
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
73956
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251182Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135744
GnomAD3 exomes
AF:
AC:
3
AN:
251182
Hom.:
AF XY:
AC XY:
1
AN XY:
135744
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461658Hom.: 0 Cov.: 30 AF XY: 0.00000825 AC XY: 6AN XY: 727138
GnomAD4 exome
AF:
AC:
15
AN:
1461658
Hom.:
Cov.:
30
AF XY:
AC XY:
6
AN XY:
727138
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151654Hom.: 0 Cov.: 31 AF XY: 0.0000270 AC XY: 2AN XY: 74084
GnomAD4 genome
AF:
AC:
2
AN:
151654
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
74084
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Surfactant metabolism dysfunction, pulmonary, 4 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 14, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at